Concepts (225)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracellular Signaling Peptides and Proteins | 18 | 2025 | 285 | 2.220 |
Why?
|
| Carcinoma, Pancreatic Ductal | 4 | 2025 | 146 | 0.830 |
Why?
|
| Pancreatic Neoplasms | 6 | 2025 | 548 | 0.790 |
Why?
|
| Intestinal Mucosa | 6 | 2020 | 198 | 0.700 |
Why?
|
| Neoplastic Stem Cells | 9 | 2020 | 141 | 0.680 |
Why?
|
| Biomarkers, Tumor | 6 | 2024 | 415 | 0.620 |
Why?
|
| Colitis | 2 | 2018 | 54 | 0.590 |
Why?
|
| Gene Deletion | 2 | 2015 | 120 | 0.550 |
Why?
|
| MicroRNAs | 7 | 2024 | 302 | 0.530 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2020 | 472 | 0.510 |
Why?
|
| Whole-Body Irradiation | 4 | 2016 | 40 | 0.500 |
Why?
|
| Epithelial Cells | 8 | 2018 | 265 | 0.490 |
Why?
|
| Dextran Sulfate | 1 | 2015 | 9 | 0.470 |
Why?
|
| Colon | 2 | 2018 | 123 | 0.470 |
Why?
|
| Liver Neoplasms | 5 | 2024 | 167 | 0.460 |
Why?
|
| Stem Cells | 6 | 2016 | 123 | 0.460 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2015 | 26 | 0.450 |
Why?
|
| Colonic Neoplasms | 2 | 2017 | 122 | 0.450 |
Why?
|
| Receptors, Notch | 2 | 2014 | 44 | 0.440 |
Why?
|
| Cell Proliferation | 11 | 2025 | 824 | 0.430 |
Why?
|
| Mice | 20 | 2025 | 4802 | 0.430 |
Why?
|
| Signal Transduction | 5 | 2018 | 1469 | 0.400 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 634 | 0.370 |
Why?
|
| Animals | 24 | 2025 | 10684 | 0.360 |
Why?
|
| Histones | 1 | 2012 | 96 | 0.360 |
Why?
|
| Epithelial-Mesenchymal Transition | 7 | 2018 | 120 | 0.350 |
Why?
|
| Inflammation | 4 | 2024 | 667 | 0.350 |
Why?
|
| Alternative Splicing | 2 | 2020 | 48 | 0.300 |
Why?
|
| Apoptosis | 5 | 2018 | 780 | 0.280 |
Why?
|
| Liver Cirrhosis | 3 | 2024 | 78 | 0.270 |
Why?
|
| Cell Line, Tumor | 11 | 2025 | 1350 | 0.270 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2024 | 133 | 0.240 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2018 | 79 | 0.240 |
Why?
|
| Gelsolin | 1 | 2025 | 7 | 0.240 |
Why?
|
| Kidney Neoplasms | 2 | 2018 | 103 | 0.230 |
Why?
|
| Radiation Injuries | 2 | 2016 | 52 | 0.230 |
Why?
|
| Microtubules | 2 | 2016 | 90 | 0.220 |
Why?
|
| Benzodiazepinones | 2 | 2014 | 13 | 0.220 |
Why?
|
| Cell Survival | 5 | 2017 | 419 | 0.220 |
Why?
|
| Adenocarcinoma | 4 | 2017 | 300 | 0.210 |
Why?
|
| Xenograft Model Antitumor Assays | 7 | 2025 | 275 | 0.210 |
Why?
|
| Antineoplastic Agents | 5 | 2018 | 686 | 0.200 |
Why?
|
| Barrett Esophagus | 2 | 2014 | 16 | 0.200 |
Why?
|
| Peptides | 1 | 2025 | 296 | 0.200 |
Why?
|
| Esophageal Neoplasms | 2 | 2014 | 33 | 0.200 |
Why?
|
| Humans | 22 | 2025 | 28851 | 0.200 |
Why?
|
| Hepatocytes | 2 | 2020 | 88 | 0.180 |
Why?
|
| RNA, Messenger | 5 | 2015 | 668 | 0.180 |
Why?
|
| Cell Movement | 5 | 2020 | 376 | 0.180 |
Why?
|
| Pancreatitis | 1 | 2020 | 36 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2020 | 1653 | 0.160 |
Why?
|
| beta Catenin | 1 | 2020 | 66 | 0.160 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2018 | 120 | 0.160 |
Why?
|
| Receptor, Notch1 | 3 | 2017 | 27 | 0.150 |
Why?
|
| Gene Expression | 3 | 2015 | 417 | 0.150 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 134 | 0.150 |
Why?
|
| Intestines | 2 | 2016 | 118 | 0.140 |
Why?
|
| Antiviral Agents | 2 | 2016 | 114 | 0.140 |
Why?
|
| Stromal Cells | 2 | 2015 | 62 | 0.140 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 8 | 0.130 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 16 | 0.130 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 170 | 0.130 |
Why?
|
| Male | 6 | 2024 | 13921 | 0.130 |
Why?
|
| Hepatitis C, Chronic | 1 | 2016 | 32 | 0.120 |
Why?
|
| Case-Control Studies | 2 | 2015 | 739 | 0.120 |
Why?
|
| RNAi Therapeutics | 1 | 2015 | 13 | 0.120 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2016 | 41 | 0.120 |
Why?
|
| Pectins | 1 | 2015 | 7 | 0.120 |
Why?
|
| Mucositis | 1 | 2015 | 7 | 0.120 |
Why?
|
| Radiation-Protective Agents | 1 | 2015 | 22 | 0.120 |
Why?
|
| DNA Damage | 1 | 2016 | 152 | 0.120 |
Why?
|
| Stilbenes | 1 | 2016 | 91 | 0.120 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2015 | 31 | 0.120 |
Why?
|
| Intestine, Small | 1 | 2015 | 66 | 0.120 |
Why?
|
| CA-19-9 Antigen | 1 | 2015 | 7 | 0.110 |
Why?
|
| Focal Adhesions | 1 | 2015 | 15 | 0.110 |
Why?
|
| Female | 6 | 2024 | 15624 | 0.110 |
Why?
|
| Up-Regulation | 5 | 2015 | 247 | 0.110 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2014 | 13 | 0.110 |
Why?
|
| Intestinal Neoplasms | 1 | 2014 | 15 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2015 | 124 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2018 | 332 | 0.110 |
Why?
|
| Biomarkers | 2 | 2016 | 776 | 0.110 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2013 | 22 | 0.100 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 480 | 0.100 |
Why?
|
| Virus Replication | 1 | 2013 | 66 | 0.100 |
Why?
|
| Hepacivirus | 1 | 2013 | 49 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2014 | 128 | 0.100 |
Why?
|
| Wound Healing | 1 | 2014 | 126 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2014 | 165 | 0.100 |
Why?
|
| Cell Differentiation | 1 | 2015 | 427 | 0.100 |
Why?
|
| Indoles | 1 | 2013 | 110 | 0.100 |
Why?
|
| Neovascularization, Pathologic | 1 | 2013 | 148 | 0.090 |
Why?
|
| Carcinogenesis | 2 | 2024 | 81 | 0.090 |
Why?
|
| Esophagus | 1 | 2012 | 72 | 0.090 |
Why?
|
| Middle Aged | 3 | 2024 | 7414 | 0.090 |
Why?
|
| Carcinoma | 1 | 2011 | 74 | 0.080 |
Why?
|
| Disease Models, Animal | 4 | 2018 | 1507 | 0.080 |
Why?
|
| RNA Interference | 3 | 2015 | 137 | 0.080 |
Why?
|
| Chronic Disease | 2 | 2024 | 274 | 0.080 |
Why?
|
| Survival Analysis | 3 | 2016 | 288 | 0.080 |
Why?
|
| Aged | 2 | 2024 | 5598 | 0.080 |
Why?
|
| Tumor Burden | 3 | 2015 | 110 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2017 | 513 | 0.080 |
Why?
|
| Colorectal Neoplasms | 1 | 2011 | 142 | 0.080 |
Why?
|
| Blotting, Western | 3 | 2016 | 515 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 328 | 0.080 |
Why?
|
| Protein Binding | 2 | 2025 | 667 | 0.070 |
Why?
|
| RNA-Binding Proteins | 3 | 2014 | 87 | 0.070 |
Why?
|
| 5'-Nucleotidase | 1 | 2008 | 13 | 0.070 |
Why?
|
| Adenosine | 1 | 2008 | 33 | 0.070 |
Why?
|
| Mice, Knockout | 3 | 2018 | 874 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2008 | 103 | 0.070 |
Why?
|
| Spheroids, Cellular | 2 | 2020 | 53 | 0.070 |
Why?
|
| Nanoparticles | 1 | 2011 | 291 | 0.070 |
Why?
|
| Endotoxemia | 1 | 2006 | 8 | 0.060 |
Why?
|
| Protein C | 2 | 2006 | 38 | 0.060 |
Why?
|
| Hemostasis | 1 | 2006 | 48 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 285 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2006 | 114 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2018 | 314 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2006 | 124 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2018 | 198 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2008 | 334 | 0.060 |
Why?
|
| Prognosis | 2 | 2018 | 811 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2024 | 52 | 0.050 |
Why?
|
| Gene Expression Profiling | 2 | 2017 | 465 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2014 | 44 | 0.050 |
Why?
|
| Adult | 1 | 2015 | 8024 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2013 | 202 | 0.050 |
Why?
|
| Blood Coagulation Factors | 1 | 2002 | 31 | 0.050 |
Why?
|
| Phospholipids | 1 | 2002 | 76 | 0.050 |
Why?
|
| SOX9 Transcription Factor | 1 | 2020 | 12 | 0.040 |
Why?
|
| alpha-Fetoproteins | 1 | 2020 | 18 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 31 | 0.040 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2020 | 42 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 66 | 0.040 |
Why?
|
| Pancreas | 1 | 2020 | 63 | 0.040 |
Why?
|
| Macrophage Activation | 1 | 2020 | 32 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2015 | 523 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2020 | 119 | 0.040 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 137 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2020 | 194 | 0.040 |
Why?
|
| Genes, APC | 1 | 2017 | 14 | 0.030 |
Why?
|
| Survival Rate | 1 | 2018 | 432 | 0.030 |
Why?
|
| Enterocytes | 1 | 2016 | 15 | 0.030 |
Why?
|
| Cell Membrane Permeability | 1 | 2016 | 44 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2017 | 126 | 0.030 |
Why?
|
| Dinoprostone | 1 | 2016 | 42 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 32 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 68 | 0.030 |
Why?
|
| Integrases | 1 | 2016 | 39 | 0.030 |
Why?
|
| Lipopolysaccharides | 2 | 2008 | 157 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2015 | 66 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2015 | 49 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 163 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 75 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2015 | 35 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 1032 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 585 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 133 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2016 | 292 | 0.030 |
Why?
|
| Transfection | 1 | 2015 | 319 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2014 | 16 | 0.030 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2014 | 6 | 0.030 |
Why?
|
| Laminin | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2014 | 60 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 50 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2014 | 38 | 0.030 |
Why?
|
| Lentivirus | 1 | 2014 | 16 | 0.030 |
Why?
|
| ras Proteins | 1 | 2014 | 43 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 50 | 0.030 |
Why?
|
| Longevity | 1 | 2015 | 141 | 0.030 |
Why?
|
| Molecular Docking Simulation | 1 | 2014 | 53 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2014 | 88 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 257 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2014 | 62 | 0.030 |
Why?
|
| Adenoma | 1 | 2014 | 61 | 0.030 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2014 | 45 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 20 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2013 | 32 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2014 | 118 | 0.030 |
Why?
|
| Transcriptome | 1 | 2015 | 231 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2015 | 152 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 140 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 465 | 0.030 |
Why?
|
| Phenotype | 1 | 2015 | 685 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 65 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2015 | 344 | 0.030 |
Why?
|
| Binding Sites | 1 | 2014 | 355 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 485 | 0.020 |
Why?
|
| Collagen | 1 | 2014 | 156 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 867 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2015 | 1022 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2015 | 272 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 65 | 0.020 |
Why?
|
| Dipeptides | 1 | 2011 | 22 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 54 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 1613 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2012 | 87 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 1280 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2012 | 154 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 490 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 2635 | 0.020 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2008 | 1 | 0.020 |
Why?
|
| Receptor, Adenosine A2B | 1 | 2008 | 2 | 0.020 |
Why?
|
| Venules | 1 | 2008 | 3 | 0.020 |
Why?
|
| L-Selectin | 1 | 2008 | 11 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2008 | 8 | 0.020 |
Why?
|
| Adenosine Monophosphate | 1 | 2008 | 21 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2008 | 251 | 0.020 |
Why?
|
| Endothelial Protein C Receptor | 1 | 2006 | 7 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 58 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2008 | 143 | 0.020 |
Why?
|
| Solubility | 1 | 2006 | 73 | 0.020 |
Why?
|
| Heterozygote | 1 | 2006 | 69 | 0.020 |
Why?
|
| Thrombin | 1 | 2006 | 69 | 0.020 |
Why?
|
| Thrombosis | 1 | 2006 | 150 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2006 | 485 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2002 | 46 | 0.010 |
Why?
|
| CHO Cells | 1 | 2002 | 96 | 0.010 |
Why?
|
| Cricetinae | 1 | 2002 | 131 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 222 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 416 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2002 | 452 | 0.010 |
Why?
|